Search Results - Robert C. Smallridge

Refine Results
  1. 1
    Approach to the Patient with Anaplastic Thyroid Carcinoma

    Approach to the Patient with Anaplastic Thyroid Carcinoma by Robert C. Smallridge

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies

    Anaplastic Thyroid Carcinoma: Pathogenesis and Emerging Therapies by Robert C. Smallridge, John A. Copland

    Published 2010
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Inherited Antithrombin-III Deficiency Causing Mesenteric Venous Infarction

    Inherited Antithrombin-III Deficiency Causing Mesenteric Venous Infarction by James C. Gruenberg, Robert C. Smallridge, Robert Rosenberg

    Published 1975
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies

    Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies by Robert C. Smallridge, Laura A. Marlow, John A. Copland

    Published 2008
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Undetectable Sensitive Serum Thyroglobulin (<0.1 ng/ml) in 163 Patients with Follicular Cell-Derived Thyroid Cancer: Results of rhTSH Stimulation and Neck Ultrasonography and Long-Term Biochemical and Clinical Follow-Up

    Undetectable Sensitive Serum Thyroglobulin (<0.1 ng/ml) in 163 Patients with Follicular Cell-Derived Thyroid Cancer: Results of rhTSH Stimulation and Neck Ultrasonography an... by Ana Maria Chindriş, Nancy N. Diehl, Julia E. Crook, Vahab Fatourechi, Robert C. Smallridge

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Thyrotropin-Secreting Pituitary Tumors*

    Thyrotropin-Secreting Pituitary Tumors* by Paolo Beck‐Peccoz, Françoise Brücker-Davis, Luca Persani, Robert C. Smallridge, Bruce D. Weintraub

    Published 1996
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma

    Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma by Paul Weinberger, Sithara Raju Ponny, Hongyan Xu, Shan Bai, Robert C. Smallridge, John A. Copland, Ashok Sharma

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Monitoring Thyroglobulin in a Sensitive Immunoassay Has Comparable Sensitivity to Recombinant Human TSH-Stimulated Thyroglobulin in Follow-Up of Thyroid Cancer Patients

    Monitoring Thyroglobulin in a Sensitive Immunoassay Has Comparable Sensitivity to Recombinant Human TSH-Stimulated Thyroglobulin in Follow-Up of Thyroid Cancer Patients by Robert C. Smallridge, Shon Meek, Melissa A. Morgan, Geoffrey S. Gates, Thomas Peter Fox, Stefan K. Grebe, Vahab Fatourechi

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Disparities in participation in cancer clinical trials in the United States

    Disparities in participation in cancer clinical trials in the United States by Gerardo Colón‐Otero, Robert C. Smallridge, Lawrence A. Solberg, Thomas D. Keith, Timothy A. Woodward, Floyd B. Willis, Ajani N. Dunn

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    An Independent Study of a Gene Expression Classifier (Afirma) in the Evaluation of Cytologically Indeterminate Thyroid Nodules

    An Independent Study of a Gene Expression Classifier (Afirma) in the Evaluation of Cytologically Indeterminate Thyroid Nodules by Bryan McIver, M. Regina Castro, John C. Morris, Victor Bernet, Robert C. Smallridge, Michael Henry, Laura Kosok, Honey V. Reddi

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    A Longitudinal Evaluation of Thyroid Function in Critically III Surgical Patients

    A Longitudinal Evaluation of Thyroid Function in Critically III Surgical Patients by Gary P. Zaloga, Bart Chernow, Robert C. Smallridge, RUSSELL ZAJTCHUK, Kathryn Hall-Boyer, Ronald W. Hargraves, C. Raymond Lake, Kenneth D. Burman

    Published 1985
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target

    Aberrant Lipid Metabolism in Anaplastic Thyroid Carcinoma Reveals Stearoyl CoA Desaturase 1 as a Novel Therapeutic Target by Christina A. Von Roemeling, Laura A. Marlow, Anthony B. Pinkerton, Angela M. Crist, James L. Miller, Han W. Tun, Robert C. Smallridge, John A. Copland

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Cinacalcet Hydrochloride Reduces the Serum Calcium Concentration in Inoperable Parathyroid Carcinoma

    Cinacalcet Hydrochloride Reduces the Serum Calcium Concentration in Inoperable Parathyroid Carcinoma by Shonni J. Silverberg, Mishaela R. Rubin, Charles Faiman, Munro Peacock, Dolores Shoback, Robert C. Smallridge, L. E. Schwanauer, Kurt Olson, Preston Klassen, John P. Bilezikian

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification

    Deoxyribonucleic Acid Profiling Analysis of 40 Human Thyroid Cancer Cell Lines Reveals Cross-Contamination Resulting in Cell Line Redundancy and Misidentification by Rebecca E. Schweppe, Joshua Klopper, Christopher Korch, Umarani Pugazhenthi, Miriam Benezra, Jeffrey A. Knauf, James A. Fagin, Laura A. Marlow, John A. Copland, Robert C. Smallridge, Bryan R. Haugen

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    miR30a Inhibits LOX Expression and Anaplastic Thyroid Cancer Progression

    miR30a Inhibits LOX Expression and Anaplastic Thyroid Cancer Progression by Myriem Boufraqech, Naris Nilubol, Lisa Zhang, Sudheer Kumar Gara, Samira M. Sadowski, Amit Mehta, Mei He, Sean Davis, Jennifer L. Dreiling, John A. Copland, Robert C. Smallridge, Martha Quezado, Electron Kebebew

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer

    Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer by Lisa Zhang, Yaqin Zhang, Amit Mehta, Myriem Boufraqech, Sean Davis, Jing Wang, Ze Tian, Zhiya Yu, Matthew B. Boxer, Jeffrey Kiefer, John A. Copland, Robert C. Smallridge, Zhuyin Li, Min Shen, Electron Kebebew

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer

    Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer by Crescent R. Isham, Ayoko R. Bossou, Vivian Negron, Kelly E. Fisher, Rakesh Kumar, Laura A. Marlow, Wilma L. Lingle, Robert C. Smallridge, Eric J. Sherman, Vera J. Suman, John A. Copland, Keith C. Bible

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Clinical and Molecular Features of Hürthle Cell Carcinoma of the Thyroid

    Clinical and Molecular Features of Hürthle Cell Carcinoma of the Thyroid by Ana-Maria Chindris, John D. Casler, Victor Bernet, Michael Rivera, Colleen Thomas, Jennifer M. Kachergus, Brian M. Necela, Ian Hay, Sydney A. Westphal, Clive S. Grant, Geoffrey B. Thompson, Richard T. Schlinkert, E. Aubrey Thompson, Robert C. Smallridge

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial

    Efatutazone, an Oral PPAR-γ Agonist, in Combination With Paclitaxel in Anaplastic Thyroid Cancer: Results of a Multicenter Phase 1 Trial by Robert C. Smallridge, John A. Copland, Marcia S. Brose, J. Trad Wadsworth, Yariv Houvras, Michael E. Menefee, Keith C. Bible, Manisha H. Shah, Ann W. Gramza, Joshua Klopper, Laura A. Marlow, Michael G. Heckman, Reinhard von Roemeling

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth

    Reactivation of Suppressed RhoB is a Critical Step for the Inhibition of Anaplastic Thyroid Cancer Growth by Laura A. Marlow, Lisa A. Reynolds, Alan S. Cleland, Simon Cooper, Michelle L. Gumz, Shinichi Kurakata, Kôsaku Fujiwara, Ying Zhang, Thomas Sebo, Clive S. Grant, Bryan McIver, J. Trad Wadsworth, Derek C. Radisky, Robert C. Smallridge, John A. Copland

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: